The composition and metabolism of high density lipoprotein subfractions. 1979

E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer

The composition and metabolism of high density lipoprotein (HDL) subfractions were investigated in seven normal individuals. Mean HDL2 (d, 1.063-1.125 g/ml) composition (by weight) was 43% protein, 28% phospholipid, 23% cholesterol, and 6% triglyceride, and mean HDL3 (d, 1.125-1.21 g/ml) composition was 58% protein, 22% phospholipid, 14% cholesterol, and 5% triglyceride. The mean apoA-I; apoA-II weight ratio was 4.75 for HDL2 and 3.65 for HDL3. HDL2 protein was proportionally slightly richer in C apolipoproteins and higher molecular weight constituents (including apoE) than HDL3. Kinetic studies utilized radiolabeled HDLA (d, 1.09-1.21 g/ml), HDL2, and HDL3 demonstrated rapid exchange of apoA-I and apoA-II radioactivity among HDL subfractions, similar fractional rates of catabolism of apoA-I and apo A-II within HDL, and similar radioactivity decay within HDL subfractions. Mean plasma residence time was 5.74 days for radiolabeled HDL2 and 5.70 days for radiolabedled HDL3. Differences in HDL protein mass among individuals were largely due to alterations in catabolism, and in general both HDL2 and HDL3 were catabolized via a plasma and a nonplasma pathway. Data from simultaneous radiolabeled very low density lipoprotein and HDL studies in 2 individuals are consistent with the concept that apoC-II and apoC-III are catabolized at a different rate than are apo A-I and apo A-II within the HDL density range.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein

Related Publications

E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
August 1999, Current opinion in lipidology,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
August 1979, Atherosclerosis,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
June 1993, The American journal of medicine,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
April 2001, Journal of lipid research,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
January 1978, Biochemical Society transactions,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
January 2007, Journal of lipid research,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
December 1990, Biochemical Society transactions,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
June 2014, Current opinion in lipidology,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
February 1981, Journal of lipid research,
E J Schaefer, and D M Foster, and L L Jenkins, and F T Lindgren, and M Berman, and R I Levy, and H B Brewer
January 1980, Voprosy meditsinskoi khimii,
Copied contents to your clipboard!